---
schema_version: "secwatch.filing_event.v1"
accession: "0001000228-22-000030"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2022-05-03T23:59:59+00:00"
generated_at: "2026-06-26T01:09:38.380451+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Henry Schein Q1 record sales $3.2B (+8.7% YoY), EPS $1.30 beats prior year; reaffirms FY2022 guidance

## Summary
- Net sales $3.2B, +8.7% YoY; GAAP diluted EPS $1.30 vs $1.16 YoY.
- Global Dental sales $1.8B (+2.2% YoY); Global Medical $1.2B (+18.3%).
- Global Technology & Value-Added Services sales $179M (+23.4%), driven by Henry Schein One.
- FY2022 GAAP EPS guidance reaffirmed $4.75-$4.91 (7-10% growth); sales growth guidance narrowed to 5-8%.
- $200M remaining in share repurchase authority; no shares bought in Q1.

## SEC filing metadata
- accession: 0001000228-22-000030
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2022-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000030/0001000228-22-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000100022822000030/hsic-20220503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001000228-22-000030
- JSON: https://secwatch.observer/filing/0001000228-22-000030.json
- Plain text: https://secwatch.observer/filing/0001000228-22-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.